Abstract
There is cumulative evidence that the degree of inflammation correlates with prognosis after percutaneous coronary interventions (PCI). Additionally, there is a cross-link between platelet activation and inflammatory pathways. The aim of the present analysis was to evaluate the association of inflammatory markers and effects of dual antiplatelet therapy on platelet function and outcome in patients undergoing PCI.
Original language | English |
---|---|
Pages (from-to) | 256-62 |
Number of pages | 7 |
Journal | Atherosclerosis |
Volume | 213 |
Issue number | 1 |
DOIs | |
Publication status | Published - Nov 2010 |
Keywords
- Acute Coronary Syndrome
- Aged
- Angioplasty, Balloon
- Aspirin
- Blood Platelets
- C-Reactive Protein
- Cardiovascular Diseases
- Coronary Artery Disease
- Female
- Humans
- Inflammation
- Male
- Pilot Projects
- Platelet Activation
- Stents
- Ticlopidine
- Treatment Outcome